Evidence map›Paper›PMID 39662829›Full record

ArticleThe Journal of biological chemistry2025

Chaperone-mediated disaggregation of infectious prions releases particles that seed new prion formation in a strain-specific manner.

Daniel Shoup, Suzette A Priola

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Recent insights into HSP70: proteostasis and beyond.Frontiers in molecular biosciences · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel ShoupRocky Mountain Laboratories, Laboratory of Neurological Infections and Immunity, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA. Electronic address: daniel.shoup@nih.gov.
Suzette A PriolaRocky Mountain Laboratories, Laboratory of Neurological Infections and Immunity, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mammalian prion protein can form infectious, nonnative, and protease resistant aggregates (PrP

Indexed as

Heat-Shock ProteinsHSP110 Heat-Shock ProteinsPrionsProtein AggregatesAnimalsEndoplasmic Reticulum Chaperone BiPHumansMiceProtein FoldingSpecies SpecificityEndoplasmic Reticulum Chaperone BiPHeat-Shock ProteinsHSP110 Heat-Shock ProteinsHSPA5 protein, humanHspa5 protein, mousePrionsProtein AggregatesApg-2chaperoneGrp78Hsp105Hsp110molecular chaperoneprionprion diseaseprotein aggregationprotein stabilityRT-QuICseeding activity

Identifiers

PMID39662829
PMCPMC11758957

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.